CHICAGO - Cosmos Health Inc. (NASDAQ:COSM), a global healthcare group, announced today its strengthened strategic collaboration with C.A. Papaellinas Group in Cyprus, aiming to boost the distribution of its Sky Premium Life products. The company reported selling 68,000 units to date and projects sales to surpass 150,000 units over the next twelve months due to increased pharmacy penetration.
The enhanced partnership builds on the initial agreement dated September 20, 2023, where Cosmos Health began distributing its products in Holland & Barrett stores and pharmacies across Cyprus. The positive market response has spurred the company to expand its reach and explore further collaborative opportunities with Papaellinas beyond its current product line.
C.A. Papaellinas Group, established in 1929, is a prominent importer and distributor in Cyprus, representing a wide range of brands and operating multiple retail chains. The group has a significant turnover and employs a substantial workforce.
Greg Siokas, CEO of Cosmos Health, expressed satisfaction with the sales performance of Sky Premium Life products and the partnership with Papaellinas, anticipating increased market share.
Cosmos Health, incorporated in 2009, is a diversified healthcare group with a portfolio of proprietary brands and a global distribution platform. It engages in the manufacturing, distribution, and R&D of healthcare products and has recently entered the telehealth space.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.